DVL1 and colorectal cancer: These observations were further validated by immunohistochemistry in colorectal cancer patient samples, where DVL1 and WNT7B exhibited significantly higher and more homogeneous expression in metastatic tissues compared to non-metastatic ones (Fig. 9G, H).